April 2025

We’re pleased to share the final outputs of the COVID Cohorts Policy Insight Series, developed between March 2024 and March 2025 under the leadership of CoVICIS. These resources synthesize key policy insights from EU-funded COVID cohort consortia — including EuCARE — and are now available in modular format, as well as a full technical report:🗂️ […]

We are proud to announce that the abstract “Trajectories and Predictors of Post-COVID-19 Condition Persistence: A Prospective Evaluation in the EuCARE Study” has been accepted as a poster presentation at the ICAR Congress 2025, taking place in Padua, Italy, from May 21–23. A big thank you to Dr. Andrea Santoro and all collaborators involved in

We’re excited to share the latest research from EKUT team, now published in Computers in Biology and Medicine. “An informed deep learning model of the Omicron wave and the impact of vaccination” explores the dynamics of SARS-CoV-2 Omicron sublineages in Germany, France, and Italy using Physics-Informed Neural Networks. 🧠💉 What did they find?🔹 Key mutations

A recent article published in The Journal of Infectious Diseases explores the impact of bacterial and viral co-infections in adult patients hospitalized with COVID-19 across different SARS-CoV-2 variant periods. 📌 “Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE Project” Based on data from

We’re proud to share that three abstracts submitted by the EuCARE team to the 23rd European Meeting on HIV & Hepatitis 2025 (4-6 June) have been accepted! 📌 1 Oral Presentation “Early Detection of SARS-CoV-2 Variants in a School Cohort Using Next-Generation Sequencing: Insights from the EUCARE Project” 📌 2 Poster Presentations “EuCARE school project:

“Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential oro-faecal sources and evidence for transmission to humans” – published in Cambridge University Press. This systematic review examines the presence of infectious SARS-CoV-2 in faecal and gastrointestinal samples and assesses its potential role in transmission. Key insights from

The European Health Data Space (EHDS) is set to change how health data is accessed, shared, and protected across the EU! 🇪🇺✨ But what does this mean for us? 🔹 More control: primary use for healthcare including access and information rights for prescription, dispensation, medical products and devices and reimbursement services 🔹Taxonomy of secondary use: